Novo Nordisk secured U.S. regulatory approval for its weight-loss pill, giving the Danish drugmaker a shot at reclaiming ...

Altimmune's pemvidutide shows strong Phase IIb results for MASH, promising Phase III prospects. Read here for more analysis ...

Ozempic wins on affordability and accessibility, Mounjaro positions itself as a premium, high-efficacy option, while Wegovy remains the specialist brand for obesity.

A chart-topping achievement sparks debate over the legitimacy of music industry wins. What happened with the 14th Amendment? Abandoned vessel found 70 miles offshore in search for missing Florida ...

The shift toward E-mini S&P 500 Equal Weight futures reflects a broader trend among investors seeking to manage concentration ...

The search for life on Earth is speeding up, not slowing down. Scientists are now identifying more than 16,000 new species ...

Photographs tell a story of two mothers determined to help their babies gain enough weight to leave the hospital — only to ...

How can weight loss apps actually help Maryland residents get in shape? Take a look at the game-changing features that really ...

Key Insights Significantly high institutional ownership implies GDS Holdings' stock price is sensitive to their ...

After last season‘s struggles, the smile is back, the weight has been lifted, and Foden is playing with freedom and ...

The Albany area's top high school athletes produced big results this week in basketball, bowling, hockey, skiing and ...

The 2025 Ballon d’Or nominees entered this season with sky-high expectations, but football’s finest have experienced wildly ...